{"id":"https://openalex.org/W7225739491","doi":"https://doi.org/10.25251/3eyfgk80","title":"Bimekizumab Improves Draining Tunnel Outcomes in Patients with Moderate to Severe HS Regardless of Prior Biologic Use: 3-Year Data from BE HEARD EXT","display_name":"Bimekizumab Improves Draining Tunnel Outcomes in Patients with Moderate to Severe HS Regardless of Prior Biologic Use: 3-Year Data from BE HEARD EXT","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225739491","doi":"https://doi.org/10.25251/3eyfgk80"},"language":"en","primary_location":{"id":"doi:10.25251/3eyfgk80","doi":"https://doi.org/10.25251/3eyfgk80","is_oa":true,"landing_page_url":"https://doi.org/10.25251/3eyfgk80","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/3eyfgk80","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159205057","display_name":"Antonio Martorell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio Martorell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153527457","display_name":"Jennifer Hsiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Hsiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161372186","display_name":"Falk Bechara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Falk Bechara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160991442","display_name":"Christos Zouboulis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christos Zouboulis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006526834","display_name":"Melinda Gooderham","orcid":"https://orcid.org/0000-0001-8926-0113","observed_orcids":["https://orcid.org/0000-0001-8926-0113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melinda Gooderham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024535565","display_name":"Takuya Miyagawa","orcid":"https://orcid.org/0000-0002-4471-1635","observed_orcids":["https://orcid.org/0000-0002-4471-1635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takuya Miyagawa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5099139099","display_name":"Bartosz Lukowski","orcid":"https://orcid.org/0009-0008-0217-6313","observed_orcids":["https://orcid.org/0009-0008-0217-6313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bartosz Lukowski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110987901","display_name":"Christina Crater","orcid":"https://orcid.org/0009-0009-0642-6858","observed_orcids":["https://orcid.org/0009-0009-0642-6858"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christina Crater","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080692753","display_name":"Nicola Tilt","orcid":"https://orcid.org/0009-0003-4397-6329","observed_orcids":["https://orcid.org/0009-0003-4397-6329"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicola Tilt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5107463246","display_name":"M Porter","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martina Porter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s889","last_page":"s889"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12731","display_name":"Hidradenitis Suppurativa and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12731","display_name":"Hidradenitis Suppurativa and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12328","display_name":"Autoimmune and Inflammatory Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13328","display_name":"Osteomyelitis and Bone Disorders Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9549999833106995},{"id":"https://openalex.org/C2776002364","wikidata":"https://www.wikidata.org/wiki/Q341999","display_name":"Hidradenitis suppurativa","level":3,"score":0.6722999811172485},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.532800018787384},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5138000249862671},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42419999837875366},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4169999957084656},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3562000095844269},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.35370001196861267},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3237999975681305},{"id":"https://openalex.org/C3018822202","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Patient data","level":2,"score":0.313400000333786},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.30309998989105225}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/3eyfgk80","doi":"https://doi.org/10.25251/3eyfgk80","is_oa":true,"landing_page_url":"https://doi.org/10.25251/3eyfgk80","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/3eyfgk80","doi":"https://doi.org/10.25251/3eyfgk80","is_oa":true,"landing_page_url":"https://doi.org/10.25251/3eyfgk80","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W3006184816","https://openalex.org/W3042634019","https://openalex.org/W4252296099","https://openalex.org/W4323652685","https://openalex.org/W4391849978","https://openalex.org/W4399798018","https://openalex.org/W4404283674","https://openalex.org/W7128817645"],"related_works":[],"abstract_inverted_index":{"Introduction:":[0],"Hidradenitis":[1],"suppurativa":[2],"(HS)":[3],"is":[4,67],"a":[5,54,68],"chronic,":[6],"inflammatory":[7],"skin":[8],"disease":[9,33,455],"characterized":[10],"by":[11],"painful":[12],"lesions,":[13],"including":[14,87],"draining":[15],"tunnels":[16],"(DTs).":[17],"DTs":[18,194,212,366],"cause":[19],"irreversible":[20],"structural":[21],"damage,":[22],"negatively":[23],"impact":[24,83],"quality":[25],"of":[26,31,44,53,57,159,181,205,358,422,441,451],"life,":[27],"and":[28,119,148,161,173,201,221,242,254,276,283,296,305,322,329,339,344,349,364,375,387,393,401,406,411],"are":[29,133,155,195,217],"indicative":[30],"HS":[32,99],"progression.":[34,456],"Delays":[35],"in":[36,76,88,93,143,227,380,432],"initiating":[37],"biologic":[38,63,90,443],"treatment":[39],"beyond":[40],"the":[41,246,265,356],"therapeutic":[42],"\u201cwindow":[43],"opportunity\u201d":[45],"may":[46,60,447],"lead":[47],"to":[48,78,97,129,138,232,428,453],"increased":[49],"DT":[50,85,168,177,185,261,271,312,317,423,433],"counts.":[51],"Use":[52],"greater":[55,420],"number":[56],"prior":[58,89,442],"therapies":[59],"also":[61],"reduce":[62],"responsiveness.":[64],"Bimekizumab":[65],"(BKZ)":[66],"humanized":[69],"IgG1":[70],"monoclonal":[71],"antibody":[72],"selectively":[73],"inhibiting":[74],"IL-17F":[75],"addition":[77],"IL-17A.":[79],"We":[80],"report":[81],"BKZ":[82,139,150,233,247,266,381,397],"on":[84],"outcomes,":[86],"use":[91],"subgroups,":[92],"patients":[94,126,136,172,182,206,226,239,251,309,359,379,415,427],"with":[95,127,175,183,188,207,310,361,417],"moderate":[96,128],"severe":[98,130],"over":[100],"3":[101,111,438],"years":[102],"(148":[103],"weeks).":[104],"Procedure:":[105],"Data":[106,132,154],"were":[107,230,252,256,435],"pooled":[108],"from":[109,141],"phase":[110],"BE":[112,120],"HEARD":[113,121],"I&II":[114],"trials":[115],"(NCT04242446,":[116],"NCT04242498;":[117],"BHI&II)":[118],"EXT":[122],"(NCT04901195;":[123],"BHEXT),":[124],"for":[125,135,157,170,286,290,299,332,342,352,377,383,389],"HS.":[131],"reported":[134,196,218],"randomized":[137,231],"320mg":[140],"baseline":[142,187,214],"BHI&II":[144],"who":[145],"entered":[146,243],"BHEXT":[147],"continued":[149],"(BKZ":[151],"Total":[152,248,267],"group).":[153],"presented":[156],"subgroups":[158],"biologic-na\u00efve":[160,253],"biologic-experienced":[162,426],"patients.":[163],"Mean":[164],"(standard":[165],"deviation":[166],"[SD])":[167],"count":[169,272,318],"all":[171,287,333,378],"those":[174],"\u22651":[176,184,260,311],"at":[178,186,197,213,219,234,262,273,313,319,367],"baseline,":[179,198,274,314,320,368],"proportion":[180,204,357],"0,":[189],"1\u20132,":[190,208,362],"3\u20135,":[191,209,363],"or":[192,210],">5":[193,211,365],"Year1":[199,220,241],"(Wk48)":[200],"Year3.":[202,222],"The":[203],"achieving":[215,370],"DT=0":[216,371],"Results:":[223],"Of":[224,236],"1,014":[225],"BHI&II,":[228],"868":[229],"baseline.":[235,263],"those,":[237],"556":[238],"completed":[240],"BHEXT.":[244],"Within":[245],"group,":[249,268],"444":[250],"112":[255],"biologic-experienced;":[257],"425":[258],"had":[259],"In":[264,308],"mean":[269,315],"(SD)":[270,316],"Year1,":[275,321,355],"Year3":[277,323],"was":[278,324,372],"3.8":[279],"(4.3),":[280,326],"1.4":[281],"(2.6),":[282,338],"0.9":[284,340],"(2.0)":[285],"patients,":[288],"respectively;":[289],"biologic-na\u00efve:":[291,384,403],"3.3":[292],"(3.7),":[293,336],"1.2":[294],"(2.3),":[295],"0.8":[297],"(2.0);":[298],"biologic-experienced:":[300,390,408],"5.6":[301],"(5.7),":[302],"2.5":[303],"(3.3),":[304],"1.3":[306],"(2.0).":[307],"4.9":[325],"1.8":[327],"(2.8),":[328],"1.1":[330],"(2.2)":[331,341],"patients;":[334],"4.4":[335],"1.5":[337,350],"biologic-na\u00efve;":[343],"7.0":[345],"(5.5),":[346],"3.0":[347],"(3.4),":[348],"(2.1)":[351],"biologic-experienced.":[353],"At":[354,395],"(%)":[360],"respectively,":[369],"64.4,":[373],"48.3,":[374],"29.5":[376],"Total;":[382],"66.7,":[385],"50.8,":[386],"36.8;":[388],"50.0,":[391],"37.0,":[392],"14.3.":[394],"Year3,":[396,429],"Total:":[398],"79.0,":[399],"64.0,":[400],"44.0;":[402],"78.8,":[404],"69.1,":[405],"48.3;":[407],"80.0,":[409],"42.1,":[410],"35.5.":[412],"Conclusion:":[413],"Biologic-na\u00efve":[414],"treated":[416],"bimekizumab":[418,452],"displayed":[419],"achievement":[421],"outcomes":[424],"than":[425],"though":[430],"improvements":[431],"counts":[434],"maintained":[436],"through":[437],"years,":[439],"regardless":[440],"use.":[444],"These":[445],"results":[446],"support":[448],"early":[449],"initiation":[450],"prevent":[454]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}